News

For leaders in business, failing to learn the lessons of a crisis can be disastrous. For leaders in government, when millions ...
The mRNA platform enabled scientists to begin work on a vaccine within days of the publication of COVID-19’s genetic sequence. Clinical trials for an mRNA vaccine began weeks la ...
In June, the monoclonal antibody garadacimab (Andembry) was approved for prevention of HAE attacks at a dose of once monthly ...
Single-cell proteomics with RNA sequencing uncover hidden gene expression dynamics in stem cell differentiation.
Sarepta is facing a number of issues currently, including platform-level safety concerns, management credibility issues, etc.
Studying the process of brain formation illuminates just how much of development is a series of tiny miracles. Only a few ...
An announcement from Ionis Pharmaceuticals ( (IONS) ) is now available. On August 21, 2025, Ionis Pharmaceuticals announced that the FDA approved DAWNZERA™ (donidalorsen) for preventing hereditary ...
The approval makes donidalorsen the only treatment in the US for hereditary angioedema that is an RNA-targeted prophylactic.
The ability to correct disease-causing genetic mistakes using genome editors holds great promise in medicine, but it is not ...
Senior author Elias Sayour, M.D., Ph.D., a UF Health pediatric oncologist, said the results reveal a potential new treatment path — an alternative to surgery, radiation, and chemotherapy — with broad ...
A previously unknown virus in farmed Pacific oysters may hold the key to mass die-offs in the multimillion-dollar industry, ...
The quest for a vaccine against HIV has been going on for about 40 years — almost as long as the virus that causes AIDS has ...